Related Experiment Video

Updated: Jun 24, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Tight glycaemic control and cardiovascular disease in type 2 diabetes

Yared N Demssie1, Handrean Soran, Naveed Younis

  • 1Department of Diabetes and Endocrinology, Salford Royal Foundation, NHS Trust, UK.

British Journal of Hospital Medicine (London, England : 2005)
|April 10, 2009
PubMed

Insights

Tight glycaemic control in type 2 diabetes shows mixed results for cardiovascular events. This review examines recent trial outcomes and their impact on diabetes management strategies.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Diabetes Research

Background:

  • The established benefits of tight glycaemic control in type 2 diabetes for cardiovascular outcomes remain uncertain.
  • Recent large-scale clinical trials have produced surprising and contradictory results.
  • Understanding these outcomes is crucial for current clinical practice.

Purpose of the Study:

  • To review the background and findings of recent clinical trials on glycaemic control in type 2 diabetes.
  • To analyze the unexpected outcomes observed in these trials.
  • To discuss the implications for managing blood glucose levels in patients with type 2 diabetes.

Main Methods:

  • Literature review of recent pivotal clinical trials.
  • Synthesis of trial data regarding glycaemic control and cardiovascular events.
  • Analysis of mortality data in relation to diabetes management.

Main Results:

  • Recent trials have not consistently demonstrated a reduction in cardiovascular events or mortality with intensive glycaemic control.
  • Some studies indicate potential risks associated with aggressive blood glucose lowering.
  • The heterogeneity of trial populations and interventions complicates direct comparisons.

Conclusions:

  • The definitive role of tight glycaemic control in preventing cardiovascular complications in type 2 diabetes requires further investigation.
  • Current evidence suggests a more nuanced approach to glycaemic management may be necessary.
  • Individualized treatment strategies considering patient-specific factors are paramount.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...